ST段抬高型心肌梗死直接PCI后死亡率趋势
该研究基于丹麦西部心脏注册中心,纳入2003至2018年因STEMI接受直接PCI的19613例患者,按PCI年份分4组随访1年。1年死亡率从2003-2006年的10.8%逐步降至2015-2018年的7.7%(aHR 0.71,95%CI 0.62-0.82),绝对死亡率下降约四分之三发生在术后0-30天。
要点
- 直接PCI治疗的STEMI患者1年死亡率从2003-2006年10.8%降至2015-2018年7.7%。
- 0-30天死亡率绝对下降2.3%,31-365天仅下降1.0%。
- 早期(30天内)管理优化是改善远期生存的主要机会。
核心结论
- 在完全实施直接PCI策略的高收入欧洲国家,2003至2018年直接PCI治疗的STEMI患者1年死亡率大幅下降。
- 绝对死亡率下降约四分之三发生在直接PCI后最初30天内。
研究设计与样本
- 基于丹麦西部心脏注册中心的观察性研究,纳入2003至2018年首次因STEMI接受直接PCI的患者19613例。
- 按直接PCI年份分为4个时间段组,通过丹麦全国健康登记系统随访1年。
主要发现
- 1年死亡率从2003-2006年的10.8%降至2007-2010年的10.4%、2011-2014年的9.1%、2015-2018年的7.7%。
- 2015-2018年 vs 2003-2006年1年死亡率的调整风险比(aHR)为0.71(95%CI 0.62-0.82)。
- 0-30天死亡率绝对下降2.3%(aHR 0.69,95%CI 0.59-0.82)。
- 31-365天死亡率绝对下降1.0%(aHR 0.71,95%CI 0.56-0.90)。
临床怎么用
- 应持续优化直接PCI治疗STEMI患者的早期(30天内)管理以进一步改善总体生存。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: Observational studies have reported that mortality rates after ST-segment elevation myocardial infarction (STEMI) have been stable since 2006 to 2010. OBJECTIVES: The aim of this study was to evaluate the temporal trends in 1-year, 30-day, and 31- to 365-day mortality after STEMI in Western Denmark where primary percutaneous coronary intervention (PCI) has been the national reperfusion strategy since 2003. METHODS: Using the Western Denmark Heart Registry, the study identified first-time PCI-treated patients undergoing primary PCI (pPCI) for STEMI from 2003 to 2018. Based on the year of pPCI, patients were divided into 4 time-interval groups and followed up for 1 year using the Danish national health registries. RESULTS: A total of 19,613 patients were included. Median age was 64 years, and 74% were male. One-year mortality decreased gradually from 10.8% in 2003-2006, 10.4% in 2007-2010, 9.1% in 2011-2014, to 7.7% in 2015-2018 (2015-2018 vs 2003-2006: adjusted HR [aHR]: 0.71; 95% CI: 0.62-0.82). The largest absolute mortality decline occurred in the 0- to 30-day period with a 2.3% reduction (aHR: 0.69; 95% CI: 0.59-0.82), and to a lesser extent in the 31- to 365-day period (risk reduction: 1.0%; aHR: 0.71; 95% CI: 0.56-0.90). CONCLUSIONS: In a high-income European country with a fully implemented pPCI strategy, 1-year mortality in pPCI-treated patients with STEMI decreased substantially between 2003 and 2018. Approximately three-quarters of the absolute mortality reduction occurred within the first 30 days after pPCI. These results indicate that optimization of early management of pPCI-treated patients with STEMI offers great opportunities for improving overall survival in contemporary clinical practice.
引用
- Thrane, Olesen, Thim, et al. Mortality Trends After Primary Percutaneous Coronary Intervention for ST-Segment Elevation Myocardial Infarction. J Am Coll Cardiol. 2023. PMID: 37648359. doi:10.1016/j.jacc.2023.06.025
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。